Cargando…
Prevention of Cardiovascular Events with Pitavastatin is Associated with Increased Serum Lipoprotein Lipase Mass Level: Subgroup Analysis of the TOHO-LIP
Aim: To clarify the mechanism by which pitavastatin reduced cardiovascular (CV) events more effectively than atorvastatin in the TOHO Lipid Intervention Trial Using Pitavastatin (TOHO-LIP), the changes in (Δ) non-heparinized serum level of lipoprotein lipase mass (LPL mass) during administration of...
Autores principales: | Nagayama, Daiji, Saiki, Atsuhito, Watanabe, Yasuhiro, Yamaguchi, Takashi, Ohira, Masahiro, Sato, Naoko, Kanayama, Mizuho, Moroi, Masao, Miyashita, Yoh, Shirai, Kohji, Tatsuno, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090481/ https://www.ncbi.nlm.nih.gov/pubmed/33642441 http://dx.doi.org/10.5551/jat.62141 |
Ejemplares similares
-
CAVI-Lowering Effect of Pitavastatin May Be Involved in the Prevention of Cardiovascular Disease: Subgroup Analysis of the TOHO-LIP
por: Saiki, Atsuhito, et al.
Publicado: (2021) -
The Anti-Cancer Effect of Pitavastatin May Be a Drug-Specific Effect: Subgroup Analysis of the TOHO-LIP Study
por: Nagayama, Daiji, et al.
Publicado: (2021) -
New Horizons of Arterial Stiffness Developed Using Cardio-Ankle Vascular Index (CAVI)
por: Saiki, Atsuhito, et al.
Publicado: (2020) -
Lipid Parameters are Independently Associated with Cardio–Ankle Vascular Index (CAVI) in Healthy Japanese Subjects
por: Nagayama, Daiji, et al.
Publicado: (2018) -
High hemoglobin glycation index is associated with increased systemic
arterial stiffness independent of hyperglycemia in real-world Japanese
population: A cross-sectional study
por: Nagayama, Daiji, et al.
Publicado: (2020)